Literature DB >> 29384144

Immunotherapy: Oncolytic viruses prime antitumour immunity.

Diana Romero.   

Abstract

Year:  2018        PMID： 29384144     DOI： 10.1038/nrclinonc.2018.15

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy.

Authors:  Marie-Claude Bourgeois-Daigneault; Dominic Guy Roy; Amelia Sadie Aitken; Nader El Sayes; Nikolas Tim Martin; Oliver Varette; Theresa Falls; Lauren Elizabeth St-Germain; Adrian Pelin; Brian Dennis Lichty; David Francis Stojdl; Guy Ungerechts; Jean-Simon Diallo; John Cameron Bell
Journal:  Sci Transl Med       Date:  2018-01-03       Impact factor: 17.956

2.  Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.

Authors:  Adel Samson; Karen J Scott; David Taggart; Emma J West; Erica Wilson; Gerard J Nuovo; Simon Thomson; Robert Corns; Ryan K Mathew; Martin J Fuller; Timothy J Kottke; Jill M Thompson; Elizabeth J Ilett; Julia V Cockle; Philip van Hille; Gnanamurthy Sivakumar; Euan S Polson; Samantha J Turnbull; Elizabeth S Appleton; Gemma Migneco; Ailsa S Rose; Matthew C Coffey; Deborah A Beirne; Fiona J Collinson; Christy Ralph; D Alan Anthoney; Christopher J Twelves; Andrew J Furness; Sergio A Quezada; Heiko Wurdak; Fiona Errington-Mais; Hardev Pandha; Kevin J Harrington; Peter J Selby; Richard G Vile; Stephen D Griffin; Lucy F Stead; Susan C Short; Alan A Melcher
Journal:  Sci Transl Med       Date:  2018-01-03       Impact factor: 17.956
  2 in total
  5 in total

1.  Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer.

Authors:  Xuan Yi; Hailin Zhou; Yu Chao; Saisai Xiong; Jing Zhong; Zhifang Chai; Kai Yang; Zhuang Liu
Journal:  Sci Adv       Date:  2020-08-14       Impact factor: 14.136

Review 2.  Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy.

Authors:  Xianyao Wang; Xing Zhao; Zhixu He
Journal:  Oncol Lett       Date:  2021-01-28       Impact factor: 2.967

3.  Aptamer-assisted tumor localization of bacteria for enhanced biotherapy.

Authors:  Zhongmin Geng; Zhenping Cao; Rui Liu; Ke Liu; Jinyao Liu; Weihong Tan
Journal:  Nat Commun       Date:  2021-11-15       Impact factor: 14.919

4.  Immune Checkpoint Blockade Augments Changes Within Oncolytic Virus-induced Cancer MHC-I Peptidome, Creating Novel Antitumor CD8 T Cell Reactivities.

Authors:  Youra Kim; Prathyusha Konda; J Patrick Murphy; Joao A Paulo; Steven P Gygi; Shashi Gujar
Journal:  Mol Cell Proteomics       Date:  2021-12-16       Impact factor: 5.911

5.  Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens.

Authors:  Yong Luo; Chaolong Lin; Yidi Zou; Fei Ju; Wenfeng Ren; Yanhua Lin; Yale Wang; Xiaoxuan Huang; Huiling Liu; Zeng Yu; Pingguo Liu; Guowei Tan; Quan Yuan; Jun Zhang; Chenghao Huang; Ningshao Xia
Journal:  Oncoimmunology       Date:  2020-02-12       Impact factor: 8.110
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.